tiprankstipranks
BioNTech SE (BNTX)
NASDAQ:BNTX
US Market

BioNTech SE (BNTX) Financial Statements

Compare
4,469 Followers

BioNTech SE Financial Overview

BioNTech SE's market cap is currently $29.43B. The company's EPS TTM is $-2.1; its P/E ratio is ―; BioNTech SE is scheduled to report earnings on March 10, 2025, and the estimated EPS forecast is $0.34. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21Dec 20Dec 19
Income Statement
Total Revenue€ 3.82B€ 17.31B€ 18.98B€ 482.32M€ 108.59M
Gross Profit€ 3.22B€ 12.78B€ 15.12B€ -222.04M€ -135.24M
Operating Income€ 690.40M€ 12.64B€ 15.28B€ -82.42M€ -181.52M
EBITDA€ 1.09B€ 12.43B€ 15.00B€ -105.10M€ -152.30M
Net Income€ 930.30M€ 9.43B€ 10.29B€ 15.20M€ -179.17M
Balance Sheet
Cash & Short-Term Investments€ 16.55B€ 14.06B€ 2.07B€ 1.35B€ 520.83M
Total Assets€ 23.01B€ 23.28B€ 15.83B€ 2.32B€ 797.65M
Total Debt€ 219.10M€ 212.20M€ 301.50M€ 240.19M€ 68.90M
Net Debt€ -11.44B€ -13.66B€ -1.39B€ -970.02M€ -450.25M
Total Liabilities€ 2.76B€ 3.22B€ 3.94B€ 946.77M€ 304.15M
Stockholders' Equity€ 20.25B€ 20.06B€ 11.89B€ 1.37B€ 493.49M
Cash Flow
Free Cash Flow€ 4.67B€ 13.21B€ 735.70M€ -98.92M€ -269.62M
Operating Cash Flow€ 5.37B€ 13.58B€ 889.70M€ -13.47M€ -198.54M
Investing Cash Flow€ -6.95B€ -35.30M€ -566.10M€ -144.85M€ -77.11M
Financing Cash Flow€ -778.60M€ -1.42B€ 94.20M€ 894.73M€ 383.29M
Currency in EUR

BioNTech SE Earnings and Revenue History

BioNTech SE Debt to Assets

BioNTech SE Cash Flow

BioNTech SE Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis